Apple Self Repair Programm wird mit Diagnostik-Tool aufgewertet

The high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has – for the first time – enabled researchers to see how individual living cancer cells react to treatment and change over time – providing vital understanding that could help doctors develop more effective cancer medication. …

Vom 9. bis 11. April 2024 läuft in den Berliner Messehallen die DMEA – wodurch sich wieder alles rund um das Thema Digital Health dreht. Mit über 750 nationalen und internationalen Ausstellern, über 300 Speakern und mehr als 16.000 erwarteten Teilnehmern ist die DMEA Europas Leitveranstaltung für die digitale Gesundheitsversorgung. Studierende / Schüler:innen: erhalten ein…

The increasing demand in the embedded field has led to the emergence of several impressive Instruction Set Architectures (ISAs). However, when processors migrate from one ISA to another, software compatibility issues are unavoidable. Despite the availability of software binary translation systems for ensuring software compatibility, these systems have limitations (e.g. performance and power) in low-cost…

Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a research collaboration with the Food and Drug Administration (FDA). This multi-year research endeavor will begin with research to investigate the differences in scoring algorithms used in diagnostic tests to determine whether a patient is a suitable candidate for immune…

FARMINGTON HILLS, Mich., Feb. 23, 2024  — Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that George Magrath, M.D. M.B.A, M.S. CEO of Ocuphire, will be presenting a company overview at the BIO CEO…